Odonate Therapeutics, Inc. (ODTC)
Total Valuation
ODTC has a market cap or net worth of $56.97 million. The enterprise value is -$33.93 million.
| Market Cap | 56.97M |
| Enterprise Value | -33.93M |
Important Dates
The latest earnings date was Monday, February 21, 2022, before market open.
| Last Earnings Date | Feb 21, 2022 |
| Ex-Dividend Date | n/a |
Share Statistics
ODTC has 38.49 million shares outstanding. The number of shares has increased by 15.54% in one year.
| Shares Outstanding | 38.49M |
| Shares Change (YoY) | +15.54% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.76% |
| Owned by Institutions (%) | 20.60% |
| Float | 31.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.80 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.29, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.29 |
| Quick Ratio | 3.16 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -102.70%, which is considered low.
| Return on Equity (ROE) | -102.70% |
| Return on Assets (ROA) | -76.30% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$745,007 |
| Employee Count | 137 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +32.14% in the last 52 weeks. The beta is 0.40, so ODTC's price volatility has been lower than the market average.
| Beta (1Y) | 0.40 |
| 52-Week Price Change | +32.14% |
| 50-Day Moving Average | 1.52 |
| 200-Day Moving Average | 1.35 |
| Average Volume (30 Days) | 51,922 |
Short Selling Information
The latest short interest is 379,628, so 0.99% of the outstanding shares have been sold short.
| Short Interest | 379,628 |
| Short % of Shares Out | 0.99% |
| Short % of Float | 1.22% |
| Short Ratio (days to cover) | 0.59 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -102.32M |
| Net Income | -102.07M |
| EBITDA | -101.00M |
| EBIT | -102.07M |
| Earnings Per Share (EPS) | -$2.71 |
Balance Sheet
The company has $95.74 million in cash and $4.85 million in debt, giving a net cash position of $90.89 million or $2.36 per share.
| Cash & Cash Equivalents | 95.74M |
| Total Debt | 4.85M |
| Net Cash | 90.89M |
| Net Cash Per Share | $2.36 |
| Book Value | 71.37M |
| Book Value Per Share | 1.85 |
| Working Capital | 69.29M |
Cash Flow
In the last 12 months, operating cash flow was -$94.54 million and capital expenditures -$42,000, giving a free cash flow of -$94.58 million.
| Operating Cash Flow | -94.54M |
| Capital Expenditures | -42,000 |
| Free Cash Flow | -94.58M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ODTC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -179.17% |
| FCF Yield | -166.03% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.54% |
| Shareholder Yield | -15.54% |
Analyst Forecast
The average price target for ODTC is $4.08, which is 175.68% higher than the current price. The consensus rating is "Sell".
| Price Target | $4.08 |
| Price Target Difference | 175.68% |
| Analyst Consensus | Sell |
| Analyst Count | 7 |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |